» Articles » PMID: 33614509

Identification of Primary and Metastatic Lung Cancer-Related LncRNAs and Potential Targeted Drugs Based on CeRNA Network

Overview
Journal Front Oncol
Specialty Oncology
Date 2021 Feb 22
PMID 33614509
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Lung cancer metastasis is the leading cause of poor prognosis and death for patients. Long noncoding RNAs (lncRNAs) have been validated the close correlation with lung cancer metastasis, but few comprehensive analyses have reported the specific association between lncRNA and cancer metastasis, especially both competing endogenous RNA (ceRNA) regulatory relationships and functional regulatory networks. Here, we constructed primary and metastatic ceRNA networks, identified 12 and 3 candidate lncRNAs for lung adenocarcinoma (LUAD) and lung squamous cell carcinoma (LUSC) respectively and excavated some drugs that might have potential therapeutic effects on lung cancer progression. In summary, this study systematically analyzed the competitive relationships and regulatory mechanism of the repeatedly dysregulated lncRNAs in lung cancer carcinogenesis and metastasis, and provided a new idea for screening potential therapeutic drugs for lung cancer.

Citing Articles

Identification of a Plasma Exosomal lncRNA- and circRNA-Based ceRNA Regulatory Network in Patients With Lung Adenocarcinoma.

Zhu W, Zhang H, Tang L, Fang K, Lin N, Huang Y Clin Respir J. 2024; 18(10):e70026.

PMID: 39428538 PMC: 11491303. DOI: 10.1111/crj.70026.


High SNRPA1 expression leads to poor prognosis in patients with lung adenocarcinoma.

Yang J, Yang Y, Gu Y, Tong L, Liu Y, Zhang J Clin Respir J. 2023; 17(8):719-732.

PMID: 37277111 PMC: 10435942. DOI: 10.1111/crj.13647.


Identification of lncRNAs involved in response to ionizing radiation in fibroblasts of long-term survivors of childhood cancer and cancer-free controls.

Grandt C, Brackmann L, Poplawski A, Schwarz H, Marini F, Hankeln T Front Oncol. 2023; 13:1158176.

PMID: 37182169 PMC: 10174438. DOI: 10.3389/fonc.2023.1158176.


Characterization of Cell Cycle-Related Competing Endogenous RNAs Using Robust Rank Aggregation as Prognostic Biomarker in Lung Adenocarcinoma.

Yang Y, Zhang S, Guo L Front Oncol. 2022; 12:807367.

PMID: 35186743 PMC: 8853726. DOI: 10.3389/fonc.2022.807367.


Identification of a N6-Methyladenosine (m6A)-Related lncRNA Signature for Predicting the Prognosis and Immune Landscape of Lung Squamous Cell Carcinoma.

Weng C, Wang L, Liu G, Guan M, Lu L Front Oncol. 2021; 11:763027.

PMID: 34868980 PMC: 8637334. DOI: 10.3389/fonc.2021.763027.


References
1.
Fu H, Zhang J, Pan J, Zhang Q, Lu Y, Wen W . Chemoprevention of lung carcinogenesis by the combination of aerosolized budesonide and oral pioglitazone in A/J mice. Mol Carcinog. 2011; 50(12):913-21. PMC: 6015734. DOI: 10.1002/mc.20751. View

2.
Chen S, Wu H, Lv N, Wang H, Wang Y, Tang Q . LncRNA CCAT2 predicts poor prognosis and regulates growth and metastasis in small cell lung cancer. Biomed Pharmacother. 2016; 82:583-8. DOI: 10.1016/j.biopha.2016.05.017. View

3.
Zhu M, Luo Y, Xu A, Xu X, Zhong M, Ran Z . Long noncoding RNA TCONS_00026334 is involved in suppressing the progression of colorectal cancer by regulating miR-548n/TP53INP1 signaling pathway. Cancer Med. 2020; 9(22):8639-8649. PMC: 7666722. DOI: 10.1002/cam4.3473. View

4.
Ashburner M, Ball C, Blake J, Botstein D, Butler H, Cherry J . Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet. 2000; 25(1):25-9. PMC: 3037419. DOI: 10.1038/75556. View

5.
Niu Y, Ma F, Huang W, Fang S, Li M, Wei T . Long non-coding RNA TUG1 is involved in cell growth and chemoresistance of small cell lung cancer by regulating LIMK2b via EZH2. Mol Cancer. 2017; 16(1):5. PMC: 5223434. DOI: 10.1186/s12943-016-0575-6. View